Clinical trial
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
NCT01495793 is registered in ClinicalTrials.gov with UCB BIOSCIENCES, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
- Lead sponsor
- UCB BIOSCIENCES, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- May 31, 2014
- Enrollment
- 42 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.